BRIGHT MINDS BIOSCIENCES INC.
DRUG · XNASCIK 1827401fmd_0WJZ9YF27XEZ8BK2SPJP9X1TPTManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Oct 01, 2018 to Sep 30, 2024, 6 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Research and development | – | 0 | 6 | 12 | 5 | 1 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | – | (0) | (9) | (15) | (7) | (3) |